FDA Commissioner Scott Gottlieb recently said, “I’m deeply
concerned about the availability of menthol-flavored cigarettes.” He noted that menthol represents “one of the
most common and pernicious routes by which kids initiate on combustible
cigarettes” and “menthol products disproportionately and adversely affect
underserved communities. And as a matter of public health, they exacerbate
troubling disparities in health related to race and socioeconomic status that
are a major concern of mine…we need to address the impact that menthol in
cigarettes has on the public health.” (here)
In a similar vein, the Truth Initiative’s latest menthol
screed suggests that menthol smokers are primarily teens, females, minorities
and those with mental illness (here). Is that accurate?
The answer for adults can be found in the National Health
Interview Survey, the main instrument used by the CDC to track smoking in the
U.S. The NHIS collects information on
menthol about every five years. The
chart at left presents the characteristics of menthol smokers in 2015, the most
recent year for which NHIS data is available.
Of the 36.5 million American adult smokers, about 10.7
million reported that they smoked menthol cigarettes (22.4 million preferred
plain cigarettes and the rest were uncommitted). Women outnumbered men by a small margin, and
menthol smokers were broadly distributed across the age spectrum. Racial distribution figures stand out. Although Black/African American smokers
overwhelmingly favored menthol cigarettes, they were far outnumbered by White
menthol smokers.
Sixty-one percent of menthol smokers and 55% of plain
cigarette smokers were in the lowest income group. Any difference in income distribution between
menthol and plain cigarette smokers may be explained by differences in age, sex
or race. The claim that menthol use reflects
a socioeconomic disparity is not valid without further investigation.
Last year I published research showing that smoking may
contribute to depression, anxiety, or emotional problems (here). But the association has nothing to do with
menthol. In the 2015 NHIS 11% of menthol
smokers reported difficulty with activities because of these conditions. The rate was the same among plain cigarette
smokers.
Five years ago I noted in this blog that an “FDA preliminary
evaluation – reflecting data from numerous studies – does not provide evidence
of any significant differences between menthol and regular cigarettes with
respect to smoking initiation, addiction to nicotine or cessation. There is no justification for an
evidence-based decision by the FDA to ban or otherwise restrict the menthol
content in cigarettes.” (here)
It is not clear that a stronger scientific rationale for FDA
action on e-cigarettes presently exists.
If action is taken, this blog post has described the characteristics of
the 10.7 million smokers it will affect.
No comments:
Post a Comment